Biophytis Sa Quick Ratio (BPTS) starting from the fourth quarter 2023 to fourth quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Biophytis Sa  (NASDAQ: BPTS)

Biophytis Sa's Quick Ratio

BPTS's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the fourth quarter 2023, Quick Ratio fell to 0.35 below Biophytis Sa average.

Within Major Pharmaceutical Preparations industry 410 other companies have achieved higher Quick Ratio than Biophytis Sa in fourth quarter 2023. While Quick Ratio total ranking in the fourth quarter 2023 has deteriorated compared to the prior quarter from 1972 to 2571.

Explain Quick Ratio?
How much Cash & cash equivalents BPTS´s has?
What are BPTS´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

API endpoints for this dataset

https://api.csimarket.com/api/v1/companies/BPTS/financial-strength
https://api.csimarket.com/api/v1/companies/BPTS/fundamentals
https://api.csimarket.com/api/v1/companies/BPTS/fundamentals?mode=as_of&as_of=YYYY-MM-DD
Programmatic access for models, analytics, and integration workflows.
Explore the Financial Data API
Financial API Point-in-Time Financial Fundamentals API API Server API Docs API Discovery
Connect Your AI Assistant
How to Connect Your AI Assistant to CSIMarket MCP MCP Server
Access this full dataset via API
Free sample Full docs All endpoints
BPTS Quick Ratio (Dec 31 2023)
Q4		 0
Q3 		0
Q2 		0
Q1 		(Dec 31 2022)
Q4
Y / Y Current Liabilities Change -15.74 %
Y / Y Cash & cash equivalent Change -47.92 %
Quick Ratio MRQ 0.35
BPTS's Total Ranking # 2571
Seq. Current Liabilities Change 25.94 %
Seq. Cash & cash equivalent Change -1.23 %



Quick Ratio fourth quarter 2023 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 411
Healthcare Sector # 773
Overall Market # 2571


Quick Ratio Statistics
High Average Low
1.03 0.74 0.45
(Dec 31 2021)   (Dec 31 2023)




Financial Statements
Biophytis Sa's Current Liabilities $ 17 Millions Visit BPTS's Balance sheet
Biophytis Sa's Cash & cash equivalent $ 6 Millions Visit BPTS's Balance sheet
Source of BPTS's Sales Visit BPTS's Sales by Geography


Cumulative Biophytis Sa's Quick Ratio

BPTS's Quick Ratio for the trailling 12 Months

BPTS Quick Ratio

 (Dec 31 2023)
12 Months		 0
12 Months 		0
12 Months 		0
12 Months 		(Dec 31 2022)
12 Months
Y / Y Current Liabilities TTM Growth -43.66 %
Y / Y Cash & cash equivalent TTM Growth -73.12 %
Quick Ratio TTM 0.42
Total Ranking TTM # 3999
Seq. Current Liabilities TTM Growth -5.23 %
Seq. Cash & cash equivalent TTM Growth -18.56 %

Quick ratio ranking by company, industry and sector >> Back to BPTS Financial Strength Comparisons >> Go to Compare BPTS Quick Ratio to its Competitors

On the trailing twelve months basis In spite of the year on year decrease in BPTS's Current Liabilities to $17.44 millions, cumulative Quick Ratio to 0.42 below the BPTS average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 486 other companies have achieved higher Quick Ratio than Biophytis Sa. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the third quarter 2023 from 3342 to 3999.

Explain Quick Ratio?
How much Cash & cash equivalents BPTS´s has?
What are BPTS´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 487
Healthcare Sector # 991
Within the Market # 3999


trailing twelve months Quick Ratio Statistics
High Average Low
1.03 0.79 0.45
(Dec 31 2021)   (Dec 31 2023)




Companies with similar Quick Ratio in the quarter ending Dec 31 2023, within Major Pharmaceutical Preparations Industry Quick RatioDec 31 2023 MRQ Cash & cash equivalentDec 31 2023 MRQ Current Liabilities
Indivior Pharmaceuticals Inc   0.97 $ 1,146.000  Millions$ 1,181.000  Millions
Durect Corp  0.96 $ 29.680  Millions$ 31.044  Millions
Elicio Therapeutics Inc   0.93 $ 12.894  Millions$ 13.907  Millions
Zevra Therapeutics Inc   0.92 $ 67.737  Millions$ 73.720  Millions
Biomarin Pharmaceutical Inc  0.91 $ 1,073.810  Millions$ 1,177.024  Millions
Reshape Lifesciences Inc  0.91 $ 4.459  Millions$ 4.890  Millions
Vtv Therapeutics Inc   0.91 $ 9.511  Millions$ 10.433  Millions
Heron Therapeutics Inc   0.89 $ 80.409  Millions$ 90.588  Millions
Kineta Inc   0.89 $ 5.783  Millions$ 6.525  Millions
Aslan Pharmaceuticals Limited  0.86 $ 21.252  Millions$ 24.799  Millions
Transcode Therapeutics Inc   0.82 $ 2.879  Millions$ 3.491  Millions
Theratechnologies Inc   0.82 $ 68.194  Millions$ 83.051  Millions
Calcimedica Inc   0.80 $ 11.238  Millions$ 13.967  Millions
Addex Therapeutics Ltd  0.80 $ 4.599  Millions$ 5.730  Millions
Teva Pharmaceutical Industries Limited  0.78 $ 3,227.000  Millions$ 4,111.000  Millions
Xeris Biopharma Holdings Inc   0.76 $ 72.451  Millions$ 95.193  Millions
Rockwell Medical inc   0.76 $ 10.939  Millions$ 14.409  Millions
Johnson and Johnson  0.76 $ 22,927.000  Millions$ 30,281.000  Millions
Xencor Inc  0.75 $ 55.246  Millions$ 73.915  Millions
Stablecoin Development Corporation  0.73 $ 3.130  Millions$ 4.278  Millions
Assertio Holdings inc   0.73 $ 73.441  Millions$ 101.185  Millions
Effector Therapeutics Inc   0.71 $ 18.370  Millions$ 25.796  Millions
Igc Pharma Inc   0.71 $ 1.378  Millions$ 1.939  Millions
Abbott Laboratories  0.71 $ 7,279.000  Millions$ 10,295.000  Millions
Applied Therapeutics Inc   0.70 $ 49.898  Millions$ 71.182  Millions
Gri Bio Inc   0.67 $ 1.808  Millions$ 2.697  Millions
Molecular Templates Inc   0.67 $ 11.523  Millions$ 17.321  Millions
Cumberland Pharmaceuticals Inc   0.66 $ 18.322  Millions$ 27.634  Millions
Collegium Pharmaceutical Inc   0.66 $ 310.548  Millions$ 469.221  Millions
Journey Medical Corp  0.66 $ 27.439  Millions$ 41.868  Millions

Date modified: 2026-09-02T19:26:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.